ワルファリン投与量予測のためのLASSO-projアルゴリズムに基づく解釈可能なニューラルネットワークフレームワークの応用
Chenlu Zhong1, Ye Zhu2, Xiang Gu2
1Department of Cardiology, Gaoyou People's Hospital, Yangzhou, Jiangsu 225001, P. R. China.
まとめ
この研究では、患者の安全性を向上させるために、ワルファリン投与量を予測する解釈可能な機械学習モデルを開発しました。このモデルは、個別化ワルファリン治療のためのVKORC1遺伝子型、年齢、体重などの重要な要因を正確に特定します。
科学分野:
- 薬理遺伝学
- 計算生物学
- 臨床薬理学
背景:
- ワルファリンの投与は、その治療域が狭く、個人差が大きいことから、課題となっています。
- 正確な投与量の調整は困難であり、出血または血栓症のリスクを高めます。
研究 の 目的:
- 安定したワルファリン投与量を予測するための、合理化された解釈可能な多層パーセプトロン(MLP)モデルを開発すること。
- 実際のデータを使用して、ワルファリン投与量予測の精度と透明性を向上させること。
主な方法:
- 実際のデータのために、国際ワルファリン薬理遺伝学コンソーシアム(IWPC)データベースを利用しました。
- 高精度の特徴選択のためにLASSO-projアルゴリズムを適用しました。
- SHAPベースの分析のためにDeepExplainerを使用して多層パーセプトロン(MLP)モデルを開発および解釈しました。
主要な成果:
- MLPモデルは決定係数(R^2)0.456および平均絶対誤差(MAE)8.92 mg/週を達成しました。
- 予測の48.52%が実際の安定した治療用量±20%以内に収まりました。
- 主な影響因子として、VKORC1遺伝子型、体重、年齢、および人種を特定しました。
結論:
- LASSO-projを備えた解釈可能なMLPフレームワークは、ワルファリン投与量に対して高い予測精度を提供します。
- このアプローチはモデルの透明性を高め、臨床的なワルファリン療法をガイドするための貴重なツールを提供します。
- 薬理遺伝学の洞察と高度なモデリングを通じて、個別化されたワルファリン投与量を改善できます。
関連する概念動画
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
290
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
290
Pharmacokinetic Models: Comparison and Selection Criterion
304
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
304
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
455
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
455
Drug Concentration Versus Time Correlation
1.9K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
